BioCentriq CEO On Next Phase Of Growth With GC Support
Parent Understands Need For Flexibility, Autonomy In US
In a video interview with Scrip, Syed Husain, CEO of the US-based cell therapy CDMO BioCentriq, talks about the company’s role in parent GC’s growth strategy and business priorities, the cell and gene therapy manufacturing market and his views on the US BIOSECURE Act.
